Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK）
Clinical trial NCT07005570 · RECRUITING
Trial details
- NCT number
- NCT07005570
- Sponsor
- Dechang Diao
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-07-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.